Intrathecal treatment with sigma-1 receptor antagonists reduces formalin-induced phosphorylation of NMDA receptor subunit 1 and the second phase of formalin test in mice.

Br J Pharmacol 148, 490-498, (2006).

Kim, H. W., Kwon, Y. B., Roh, D. H., Yoon, S. Y., Han, H. J., Beitz, A. J., et al.

Share this: